1. Home
  2. NPWR vs HUMA Comparison

NPWR vs HUMA Comparison

Compare NPWR & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NET Power Inc.

NPWR

NET Power Inc.

HOLD

Current Price

$2.00

Market Cap

193.9M

Sector

Energy

ML Signal

HOLD

Logo Humacyte Inc.

HUMA

Humacyte Inc.

HOLD

Current Price

$1.08

Market Cap

155.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NPWR
HUMA
Founded
2010
2004
Country
United States
United States
Employees
N/A
184
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
193.9M
155.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NPWR
HUMA
Price
$2.00
$1.08
Analyst Decision
Buy
Strong Buy
Analyst Count
2
8
Target Price
$3.50
$6.19
AVG Volume (30 Days)
636.9K
4.4M
Earning Date
05-11-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$444.16
Revenue Next Year
N/A
$248.39
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.46
$0.55
52 Week High
$5.20
$2.93

Technical Indicators

Market Signals
Indicator
NPWR
HUMA
Relative Strength Index (RSI) 60.64 69.71
Support Level $1.52 $0.92
Resistance Level $2.17 $1.27
Average True Range (ATR) 0.14 0.08
MACD 0.04 0.04
Stochastic Oscillator 60.58 95.41

Price Performance

Historical Comparison
NPWR
HUMA

About NPWR NET Power Inc.

NET Power Inc is a clean energy technology company that has developed a novel power generation system, which it refers to as the NET Power Cycle, designed to produce clean, reliable, and low-cost electricity from natural gas while capturing virtually all atmospheric emissions. The company's business model is to license its technology to customers and enable them to build, own, and operate facilities that utilize the Net Power Cycle. It has conducted a successful demonstration of its technology at the La Porte Demonstration Facility and is developing a utility-scale power plant in Texas named Project Permian.

About HUMA Humacyte Inc.

Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: